Analysis of brain atrophy and local gene expression in genetic frontotemporal dementia

Frontotemporal dementia (FTD) is a heterogeneous neurodegenerative disorder characterized by neuronal loss in the frontal and temporal lobes. Despite progress in understanding which genes are associated with the aetiology of FTD, the biological basis of how mutations in these genes lead to cell loss in specific cortical regions remains unclear. In this work we combined gene expression data for 16,772 genes from the Allen Institute for Brain Science atlas with brain maps of gray matter atrophy in symptomatic C9orf72, GRN and MAPT mutation carriers obtained from the Genetic FTD Initiative study. No significant association was seen between (C9orf2, GRN and MAPT expression and the atrophy patterns in the respective genetic groups. Between 1,000 and 5,000 genes showed a negative or positive correlation with the atrophy pattern within each individual genetic group, with the most significantly associated genes being TREM2, SSBP3 and GPR158 (negative association in C9orf72, GRN and MAPT respectively) and RELN, MXRA8 and LPA (positive association in C9orf72, GRN and MAPT respectively). An overrepresentation analysis identified a negative correlation with genes involved in mitochondrial function, and a positive correlation with genes involved in vascular and glial cell function in each of the genetic groups. After adjusting for spatial autocorrelation, a set of 423 and 700 genes showed significant positive and negative correlation, respectively, with atrophy patterns in all three maps. The gene set with increased expression in spared cortical regions was enriched for neuronal and microglial genes, while the gene set with increased expression in atrophied regions was enriched for astrocyte and endothelial cell genes. Our analysis suggests that these cell types may play a more active role in the onset of neurodegeneration in FTD than previously assumed, and in the case of the positively-associated cell marker genes, potentially through emergence of neurotoxic astrocytes and alteration in the blood-brain barrier respectively. Abbreviated summary Altmann et al. investigated the concordance between spatial cortical gene expression in healthy subjects and atrophy patterns in genetic frontotemporal dementia. They found that elevated gene expression of endothelial cell and astrocyte-related genes in regions with atrophy, suggesting a role of these cell types in the aetiology of frontotemporal dementia.

[1]  Young T. Hong,et al.  In vivo PET imaging of neuroinflammation in familial frontotemporal dementia , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

[2]  W. Seeley,et al.  C9ORF72-ALS/FTD-associated poly(GR) binds Atp5a1 and compromises mitochondrial function in vivo , 2019, Nature Neuroscience.

[3]  Young T. Hong,et al.  Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum , 2019, bioRxiv.

[4]  D. Galimberti,et al.  CSF pro-orexin and amyloid-β38 expression in Alzheimer's disease and frontotemporal dementia , 2018, Neurobiology of Aging.

[5]  L. Concha,et al.  A systems-level analysis highlights microglial activation as a modifying factor in common forms of human epilepsy , 2018, bioRxiv.

[6]  Nick C Fox,et al.  Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup , 2018, Alzheimer's Research & Therapy.

[7]  Jorge Sepulcre,et al.  Molecular properties underlying regional vulnerability to Alzheimer’s disease pathology , 2018, Brain : a journal of neurology.

[8]  Lars E. Borm,et al.  Molecular Architecture of the Mouse Nervous System , 2018, Cell.

[9]  Junhyong Kim,et al.  Comprehensive catalog of dendritically localized mRNA isoforms from sub-cellular sequencing of single mouse neurons , 2019, BMC Biology.

[10]  S. Ourselin,et al.  Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study , 2018, Neurobiology of Aging.

[11]  Berislav V. Zlokovic,et al.  Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders , 2018, Nature Reviews Neurology.

[12]  A. Levey,et al.  A proteomic network approach across the ALS‐FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain , 2017, EMBO molecular medicine.

[13]  S. Bouallègue,et al.  A New Method , 2021, Black Power and the American Myth.

[14]  Christopher C. J. Miller,et al.  Disruption of ER−mitochondria signalling in fronto-temporal dementia and related amyotrophic lateral sclerosis , 2018, Cell Death & Disease.

[15]  Sohee Jeon,et al.  Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease , 2017, Science.

[16]  J. McDonald,et al.  Lipidomic and Transcriptomic Basis of Lysosomal Dysfunction in Progranulin Deficiency , 2017, Cell reports.

[17]  Param Priya Singh,et al.  Progranulin, lysosomal regulation and neurodegenerative disease , 2017, Nature Reviews Neuroscience.

[18]  Susan L Cotman,et al.  Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis , 2017, Science Translational Medicine.

[19]  M. Araúzo-Bravo,et al.  Astrocyte pathology in a human neural stem cell model of frontotemporal dementia caused by mutant TAU protein , 2017, Scientific Reports.

[20]  K. Blennow,et al.  Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype , 2017, Neurobiology of Aging.

[21]  Manoj Kumar,et al.  INGE GRUNDKE-IQBAL AWARD FOR ALZHEIMER’S RESEARCH: NEUROTOXIC REACTIVE ASTROCYTES ARE INDUCED BY ACTIVATED MICROGLIA , 2019, Alzheimer's & Dementia.

[22]  Cedric E. Ginestet,et al.  Regional expression of the MAPT gene is associated with loss of hubs in brain networks and cognitive impairment in Parkinson's disease and Progressive Supranuclear Palsy , 2016 .

[23]  L. Petrucelli,et al.  Poly(GR) in C9ORF72-Related ALS/FTD Compromises Mitochondrial Function and Increases Oxidative Stress and DNA Damage in iPSC-Derived Motor Neurons , 2016, Neuron.

[24]  T. Kielian,et al.  Astrocytes and lysosomal storage diseases , 2016, Neuroscience.

[25]  Yan Ao,et al.  Astrocyte scar formation aids central nervous system axon regeneration , 2016, Nature.

[26]  M. Rodríguez-Violante,et al.  Parkinson disease and progressive supranuclear palsy: protein expression in skin , 2016, Annals of clinical and translational neurology.

[27]  Seth G. N. Grant,et al.  Identification of Vulnerable Cell Types in Major Brain Disorders Using Single Cell Transcriptomes and Expression Weighted Cell Type Enrichment , 2016, Front. Neurosci..

[28]  E. Chang,et al.  Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse , 2016, Neuron.

[29]  N. Tomita,et al.  Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer's disease, dementia with Lewy bodies, and frontotemporal lobar degeneration , 2016, Journal of neurochemistry.

[30]  Allan R. Jones,et al.  Canonical Genetic Signatures of the Adult Human Brain , 2015, Nature Neuroscience.

[31]  Andre Altmann,et al.  Re-Annotator: Annotation Pipeline for Microarray Probe Sequences , 2015, PloS one.

[32]  B. Barres,et al.  SnapShot: Astrocytes in Health and Disease , 2015, Cell.

[33]  M. Rietschel,et al.  Correlated gene expression supports synchronous activity in brain networks , 2015, Science.

[34]  M. Sofroniew.  Astrocyte barriers to neurotoxic inflammation , 2015, Nature Reviews Neuroscience.

[35]  T. Maniatis,et al.  Astrocytes in neurodegenerative disease. , 2015, Cold Spring Harbor perspectives in biology.

[36]  Daniel Rueckert,et al.  Geodesic Information Flows: Spatially-Variant Graphs and Their Application to Segmentation and Fusion , 2015, IEEE Transactions on Medical Imaging.

[37]  D. Bates,et al.  Fitting Linear Mixed-Effects Models Using lme4 , 2014, 1406.5823.

[38]  J. Jankovic,et al.  Genetic Convergence of Parkinson’s Disease and Lysosomal Storage Disorders , 2014, Molecular Neurobiology.

[39]  A. Singleton,et al.  TREM2 variants in Alzheimer's disease. , 2013, The New England journal of medicine.

[40]  David C. Glahn.  Faculty Opinions recommendation of An anatomically comprehensive atlas of the adult human brain transcriptome. , 2012 .

[41]  Steven Finkbeiner,et al.  Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury. , 2012, The Journal of clinical investigation.

[42]  Allan R. Jones,et al.  An anatomically comprehensive atlas of the adult human brain transcriptome , 2012, Nature.

[43]  A. Ballabio,et al.  Astrocyte dysfunction triggers neurodegeneration in a lysosomal storage disorder , 2012, Proceedings of the National Academy of Sciences.

[44]  D. Galimberti,et al.  Genetics of Frontotemporal Lobar Degeneration , 2012, Front. Neur..

[45]  Patrick R Hof,et al.  Selective frontoinsular von Economo neuron and fork cell loss in early behavioral variant frontotemporal dementia. , 2012, Cerebral cortex.

[46]  Patrick R Hof,et al.  Distinctive neurons of the anterior cingulate and frontoinsular cortex: a historical perspective. , 2012, Cerebral cortex.

[47]  D. di Bernardo,et al.  Transcriptional gene network inference from a massive dataset elucidates transcriptome organization and gene function , 2011, Nucleic acids research.

[48]  C. Caltagirone,et al.  Loss of function mutations in the progranulin gene are related to pro-inflammatory cytokine dysregulation in frontotemporal lobar degeneration patients , 2011, Journal of Neuroinflammation.

[49]  橋本 衛,et al.  非 Alzheimer 型認知症 , 2011 .

[50]  Nick C Fox,et al.  Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[51]  Sébastien Ourselin,et al.  Fast free-form deformation using graphics processing units , 2010, Comput. Methods Programs Biomed..

[52]  E. Masliah,et al.  Direct Transfer of α-Synuclein from Neuron to Astroglia Causes Inflammatory Responses in Synucleinopathies* , 2010, The Journal of Biological Chemistry.

[53]  MBq 30mCi,et al.  University Health Network, , 2010 .

[54]  Nick C Fox,et al.  The heritability and genetics of frontotemporal lobar degeneration , 2009, Neurology.

[55]  Manuela M. P. Huso,et al.  Comment on ''Methods to account for spatial autocorrelation in the analysis of species distributional data: a review'' , 2009 .

[56]  Jose Julio Rodriguez,et al.  Astroglia in dementia and Alzheimer's disease , 2009, Cell Death and Differentiation.

[57]  R. G. Davies,et al.  Methods to account for spatial autocorrelation in the analysis of species distributional data : a review , 2007 .

[58]  M. Hutton,et al.  The genetics of frontotemporal lobar degeneration , 2007, Current neurology and neuroscience reports.

[59]  Philip S. Yu,et al.  A new method to measure the semantic similarity of GO terms , 2007, Bioinform..

[60]  J. Kril,et al.  Astrocytic degeneration relates to the severity of disease in frontotemporal dementia. , 2004, Brain : a journal of neurology.

[61]  S. Paul,et al.  Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides , 2004, Nature Medicine.

[62]  T. Wyss-Coray,et al.  Adult mouse astrocytes degrade amyloid-β in vitro and in situ , 2003, Nature Network Boston.

[63]  M. Cavaglià,et al.  Regional variation in brain capillary density and vascular response to ischemia , 2001, Brain Research.

[64]  C. Cotman,et al.  Astrocytes degenerate in frontotemporal dementia: possible relation to hypoperfusion , 2001, Neurobiology of Aging.

[65]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[66]  R. Iman,et al.  Rank Transformations as a Bridge between Parametric and Nonparametric Statistics , 1981 .

[67]  S. Holm.  A Simple Sequentially Rejective Multiple Test Procedure , 1979 .

[68]  P. Moran.  Notes on continuous stochastic phenomena. , 1950, Biometrika.